Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Abbott to present data at Neuroscience 2007

Abbott to present data at Neuroscience 2007

2nd November 2007

Abbott Laboratories, together with scientists from independent academic institutions, is to present data on neuronal nicotinic receptors (NNRs) at the Neuroscience 2007 satellite symposium.

The meeting will highlight a series of NNR compounds which Abbott researchers have been developing.

Selective NNR compounds, which act as agonists at specific NNR sites in the body, are being examined to treat a number of psychiatric and neurological disorders.

Timothy Wilens, associate professor of psychiatry at Harvard Medical School, indicated that despite advances made in the treatment of neurobehavioural disorders, there were still unmet medical needs.

He added that NNR agonist compounds offered a “tremendous potential” in improving the core and associated symptoms in attention-deficit hyperactivity disorder without producing common side-effects.

James Sullivan, divisional vice president of Neuroscience Discovery at Abbott, confirmed that preclinical data supported the potential of NNR agonists in alleviating the cognitive deficits associated with a variety of disorders.

“Abbott has significant experience in this area and has been among the leaders in advancing the understanding of the therapeutic potential of NNRs for more than a decade,” he added.

Last week, Abbott was ranked as a top company for diversity by two publications. The firm was named as an industry sector leader in diversity by Fortune magazine, in addition to being dubbed one of the most admired employers for 2007 by US Black Engineer and Information Technology.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.